Medistim ASA Statistics
Total Valuation
Medistim ASA has a market cap or net worth of NOK 3.12 billion. The enterprise value is 3.03 billion.
Market Cap | 3.12B |
Enterprise Value | 3.03B |
Important Dates
The next estimated earnings date is Thursday, October 24, 2024.
Earnings Date | Oct 24, 2024 |
Ex-Dividend Date | Apr 25, 2024 |
Share Statistics
Medistim ASA has 18.31 million shares outstanding. The number of shares has increased by 0.14% in one year.
Shares Outstanding | 18.31M |
Shares Change (YoY) | +0.14% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 9.98% |
Owned by Institutions (%) | 58.14% |
Float | 15.51M |
Valuation Ratios
The trailing PE ratio is 29.91 and the forward PE ratio is 27.03.
PE Ratio | 29.91 |
Forward PE | 27.03 |
PS Ratio | 5.85 |
PB Ratio | 8.15 |
P/FCF Ratio | 27.88 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.83, with an EV/FCF ratio of 27.02.
EV / Earnings | 29.00 |
EV / Sales | 5.68 |
EV / EBITDA | 19.83 |
EV / EBIT | 23.44 |
EV / FCF | 27.02 |
Financial Position
The company has a current ratio of 4.42, with a Debt / Equity ratio of 2.69.
Current Ratio | 4.42 |
Quick Ratio | 2.40 |
Debt / Equity | 2.69 |
Debt / EBITDA | 0.07 |
Debt / FCF | 0.09 |
Interest Coverage | 854.95 |
Financial Efficiency
Return on equity (ROE) is 28.31% and return on invested capital (ROIC) is 21.20%.
Return on Equity (ROE) | 28.31% |
Return on Assets (ROA) | 17.56% |
Return on Capital (ROIC) | 21.20% |
Revenue Per Employee | 3.53M |
Profits Per Employee | 691,007 |
Employee Count | 151 |
Asset Turnover | 1.16 |
Inventory Turnover | 0.73 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.51% in the last 52 weeks. The beta is 0.88, so Medistim ASA's price volatility has been lower than the market average.
Beta (5Y) | 0.88 |
52-Week Price Change | -26.51% |
50-Day Moving Average | 166.95 |
200-Day Moving Average | 189.99 |
Relative Strength Index (RSI) | 60.05 |
Average Volume (20 Days) | 21,916 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medistim ASA had revenue of NOK 533.17 million and earned 104.34 million in profits. Earnings per share was 5.70.
Revenue | 533.17M |
Gross Profit | 422.75M |
Operating Income | 129.10M |
Pretax Income | 135.31M |
Net Income | 104.34M |
EBITDA | 144.20M |
EBIT | 129.10M |
Earnings Per Share (EPS) | 5.70 |
Balance Sheet
The company has 107.06 million in cash and 10.32 million in debt, giving a net cash position of 96.74 million or 5.28 per share.
Cash & Cash Equivalents | 107.06M |
Total Debt | 10.32M |
Net Cash | 96.74M |
Net Cash Per Share | 5.28 |
Equity (Book Value) | 383.25M |
Book Value Per Share | 20.93 |
Working Capital | 279.05M |
Cash Flow
In the last 12 months, operating cash flow was 128.40 million and capital expenditures -16.40 million, giving a free cash flow of 112.00 million.
Operating Cash Flow | 128.40M |
Capital Expenditures | -16.40M |
Free Cash Flow | 112.00M |
FCF Per Share | 6.12 |
Margins
Gross margin is 79.29%, with operating and profit margins of 24.21% and 19.57%.
Gross Margin | 79.29% |
Operating Margin | 24.21% |
Pretax Margin | 25.38% |
Profit Margin | 19.57% |
EBITDA Margin | 27.05% |
EBIT Margin | 24.21% |
FCF Margin | 21.01% |
Dividends & Yields
This stock pays an annual dividend of 4.50, which amounts to a dividend yield of 2.64%.
Dividend Per Share | 4.50 |
Dividend Yield | 2.64% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 9 |
Payout Ratio | 78.76% |
Buyback Yield | -0.14% |
Shareholder Yield | 2.50% |
Earnings Yield | 3.34% |
FCF Yield | 3.59% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |